Today's Stock Analyst Downgrades

Company	Action	Brokerage	Current Price	Price Target	Rating
AVTE Aerovate Therapeutics	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.41 -14.5%	$35.00 ➝ $2.00	Overweight ➝ Equal Weight
AVTE Aerovate Therapeutics	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.41 -14.5%		Buy ➝ Hold
AVTE Aerovate Therapeutics	Downgraded by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.41 -14.5%	$27.00 ➝ $2.00	Outperform ➝ Inline
EQH Equitable	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	$40.03 0.0%	$40.00 ➝ $43.00	Buy ➝ Neutral
FSLR First Solar	Downgraded by	Janney Montgomery Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$262.37 +0.4%		Buy ➝ Neutral
OVID Ovid Therapeutics	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.79		Outperform ➝ Market Perform
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ZNTL Zentalis Pharmaceuticals	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.14 -50.7%	$29.00 ➝ $9.00	Overweight ➝ Equal Weight
ZNTL Zentalis Pharmaceuticals	Downgraded by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.14 -50.7%	$15.00 ➝ $4.00	Neutral ➝ Underperform